The various GOF phenotypes of certain mutations in p53, including early tumor onset, changed tumor spectrum, and increased propensity for metastasis were demonstrated in numerous transgenic mouse models beginning in 2000s [18,19,20,21,22,23,24,25] as well as in clinical molecular databases [26,27]. Here, TP53 is linked to neoplasm.